Neph Times Non-Sponsored
Neph Times Non-Sponsored
Advertisement
Charlotte RobinsonChronic Kidney Disease | July 10, 2025
A study found that primary care physician-nephrologist collaboration did not improve kidney or CV outcomes in stage 5 CKD.
Charlotte RobinsonAnemia and Kidney Disease | July 9, 2025
A study showed similar efficacy and cardiovascular safety between vadadustat and darbepoetin alfa for anemia with CKD.
Zachary Kon, MDKidney Transplantation | July 3, 2025
Zachary Kon, MD, CEO and co-founder of ProCure On-Demand, discussed the company's organ recovery and logistics services.
Charlotte RobinsonGout | June 30, 2025
Hyperuricemia and gout are predictors of increased prevalence and mortality of cardiac, renal, and metabolic conditions.
Victoria SochaGout | June 27, 2025
Elevated glucose uptake in adipose tissue of patients with gout may contribute to CKD progression.
Charlotte RobinsonIgA Nephropathy | June 26, 2025
We spoke with George Edward Newman, MD, a site principal investigator of the PREVAIL study of felzartamab in IgAN.
Charlotte RobinsonKidney Transplantation | June 25, 2025
Kidney transplant recipients with psoriasis have a higher risk for transplant failure.
Charlotte RobinsonKidney Transplantation | June 24, 2025
The Kidney Transplant Fast Track intervention improved patients' odds of being waitlisted, a trial found.
Charlotte RobinsonKidney Transplantation | June 23, 2025
Kidney transplant candidates and their families often feel responsible but powerless during evaluation, a survey finds.
Charlotte RobinsonHyperkalemia | June 20, 2025
Use of SGLT2i with RAASi is associated with reduced risk for hyperkalemia in the clinical setting, a study found.
Charlotte RobinsonChronic Kidney Disease | June 19, 2025
Kidney Care Partners visited called on Congress to support policies benefitting Americans with kidney disease.
Charlotte RobinsonChronic Kidney Disease | June 19, 2025
AstraZeneca and Aptar Digital Health are partnering on screening algorithms to detect CKD and other conditions.
Charlotte RobinsonChronic Kidney Disease | June 26, 2025
Study results suggest that psychosocial interventions effectively reduce depression symptoms in people with CKD.
Charlotte RobinsonDiabetes and Hypertension | June 18, 2025
Meta-analyses reaffirmed cardiovascular and renal benefits of long-acting GLP-1RAs for patients with type 2 diabetes.
Charlotte RobinsonChronic Kidney Disease | July 7, 2025
Variability in eGFR over time is associated with risks of cardiovascular and kidney outcomes and mortality in those with CKD.
Charlotte RobinsonChronic Kidney Disease | June 26, 2025
An observational study shed light on how family medical history may affect chronic kidney disease (CKD) outcomes.
Charlotte RobinsonNephrology Times | June 14, 2025
A report based on chart data and specialist surveys reveals gaps in treatment for FSGS but optimism about the drug pipeline.
Charlotte RobinsonNephrology Times | June 13, 2025
The FDA has granted Orphan Drug Designation to veverimer for anti–glomerular basement membrane (anti-GBM) disease.
Charlotte RobinsonChronic Kidney Disease | June 13, 2025
Fibrate use is associated with higher incidence of CKD but lower risk for ESKD and mortality, a study found.
Richard Furie, MDNephrology Times | June 26, 2025
Richard Furie, MD, discussed the REGENCY trial of obinutuzumab in systemic lupus erythematosus and lupus nephritis.
Advertisement